Featured Jobs
|
Retirement Plan Administration Consultant Blue Ridge Associates
|
|
ESOP Administration Consultant Blue Ridge Associates
|
|
Regional Vice President, Sales MAP Retirement USA LLC
|
|
July Business Services
|
|
BPAS
|
|
Anchor 3(16) Fiduciary Solutions
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans Daybright Financial
|
|
BPAS
|
|
Mergers & Acquisition Specialist Compass
|
|
Compass
|
|
Managing Director - Operations, Benefits Daybright Financial
|
|
Cash Balance/ Defined Benefit Plan Administrator Steidle Pension Solutions, LLC
|
|
Pentegra
|
|
Retirement Plan Consultants
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Guest Article
(From the February 21, 2005 issue of Deloitte's Washington Bulletin, a periodic update of legal and regulatory developments relating to Employee Benefits.)
On February 11, 2005, the Centers for Medicare and Medicaid Services (CMS) released its first employer waivers authorized under the Medicare Modernization Act. These six general waivers for employer or union-operated Medicare Part D prescription drug plans are class waivers available to any employer or union plans that otherwise meet the Part D rules. Plans are not required to file for the waiver or even inform CMS that the plan will be using the waiver. The waivers cover the following rules.
|
To view the waiver notice click here.
CMS's Shifting Views on Waivers
CMS's attitude about the scope of its waivers seems to be evolving over time. In the preamble to the proposed regulations, CMS maintained its waiver authority is extremely limited with respect to employers. Rather than listing the types of waivers it might grant, the preamble listed the types of employer waivers CMS would not consider. And in public meetings CMS spokespersons frequently emphasized its limited waiver authority. In spite of the final rule's waiver provisions that closely track the earlier proposal, more recently CMS has repeatedly stressed it would attempt to use the waiver authority broadly.
Nevertheless, this first round of waivers again emphasizes the waiver authority will be extended only after weighing policy goals including:
|
CMS intends to release additional waiver guidance detailing other employer group waivers CMS will approve soon. These waivers are expected to include marketing materials requirements, drug formulary requirements, and pharmacy access requirements, among others. CMS will also consider additional waiver requests relating to specific requirements on a case-by-case basis.
![]() | The information in this Washington Bulletin is general in nature only and not intended to provide advice or guidance for specific situations.
If you have questions or need additional information about articles appearing in this or previous versions of Washington Bulletin, please contact: Robert Davis 202.879.3094, Bart Massey 202.220.2104, Elizabeth Drigotas 202.879.4985, Diane McGowan 202.220.2077, Taina Edlund 202.879.4956, Martha Priddy Patterson 202.879.5634, Laura Edwards 202.879.4981, Tom Pevarnik 202.879.5314, Mike Haberman 202.879.4963, Tom Veal 312.946.2595, Stephen LaGarde 202.879.5608, Deborah Walker 202.879.4955, J.D. Lutz 202.879.5366 Copyright 2005, Deloitte. |
BenefitsLink is an independent national employee benefits information provider, not formally affiliated with the firms and companies who kindly provide much of the content and advertisements published on this Web site, including the article shown above. |